- Report
- April 2022
- 121 Pages
Asia Pacific
From €1425EUR$1,500USD£1,226GBP
- Report
- December 2018
- 113 Pages
Global
From €7595EUR$7,995USD£6,534GBP
- Database
- December 2021
United States
From €2375EUR$2,500USD£2,043GBP
- Report
- August 2019
- 410 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- February 2024
- 107 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- February 2024
- 109 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- February 2024
- 114 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- October 2023
- 81 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- October 2023
- 92 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- March 2022
- 40 Pages
Vietnam
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
United States
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
South Korea
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
Russia
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
Japan
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
Ireland
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
Germany
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
France
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
China
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 40 Pages
Brazil
From €2465EUR$2,595USD£2,121GBP
- Report
- March 2022
- 80 Pages
Africa
From €3605EUR$3,795USD£3,101GBP
Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more